BABAM2 and cancer: This indicates that BRE-AS1 may function as a ceRNA to bind miR-145-5p, thereby disrupting the inhibitory effects of miR-145-5p on downstream cancer-promoting target genes, ultimately affecting the malignant phenotype of prostate cancer (Chen et al., 2019).